retatrutide clinical trials safety retatrutide efficacy Retatrutide, an experimental weight-loss drug, has not been approved by clinical trial results safety – retatrutide dosing frequency clinical trial

Some patients say semaglutide made them feel more anxious or depressed A review of real-world data from healthcare databases and registries is underway

Purpose-built for physicians Societies take stand against off-brand GLP-1s over safety concerns A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical organizations to speak out about safety concerns

A lot of people who struggled for years with dieting suddenly started seeing real changes after starting this injectable medication

What specific risks must be emphasized when counseling high-risk patients about GLP-1 therapy, and how do you document this patient education/ informed consent